Welcome to Medications.com

Shire shares up after net income jumps - Philadelphia Inquirer

The maker of top-selling Adderall XR for attention-deficit/hyperactivity disorder also said fourth-quarter revenue rose 46 percent to $724.5 million from ...

http://www.philly.com/inquirer/bu... | Posted: Fri Feb 22 03:14:53 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea